INTRODUCTION

골수성질환에서 단독 염색체 이상으로 19번 삼염색체를 보인 2예
Two Cases of Trisomy 19 as a Sole Chromosomal Abnormality in Myeloid Disorders
Soon IL Jung, M.D. Trisomy 19 is frequently encountered in cases of chronic myeloid leukemia (CML) as a secondary abnormality: however, trisomy 19 rarely occurs as a sole chromosomal abnormality and, to date, it has only been reported in 48 hematopoietic malignancies, 1 case of adenocarcinoma and 1 case of astrocytic tumor. Here, we report two additional cases of trisomy 19 as a sole karyotypic aberration in myeloid malignancies. One of these cases involved a 6-month-old male who was diagnosed with acute myeloid leukemia minimally differentiated. His karyotype was 47,XY,+19 [20] . He expired 5 days after diagnosis. Another case occurred in an 80-yr-old female who had refractory anemia with excess blasts. Her karyotype was 47,XX,+19[16]/46,XX [4] . Four months later, her peripheral blood smears suggested that the disease had progressed, but she refused further evaluation. Based on a review of the existing literature and the results of this report, trisomy 19 not only as a secondary abnormality but also as a sole karyotypic aberration is strongly associated with myeloid disorder; however, it is not preferentially found in specific FAB subgroups of myelodysplasic syndrome or acute myeloid leukemia. 
CASE REPORTS
Case 1
A 6-month-old male was referred to our center after experiencing fever and vomiting for one week. Although 
Case 2
An 80-yr-old female with previous history of myocardial has been correlated with myeloid blast crisis of CML [4, 5] . A review conducted by Johansson et al. [3] revealed that, the 14 AML cases included in their review had had a preleukemic myelodysplastic phase; however, the clone con- Even though Daskalakis et al. [7] concluded that trisomy 19 as a sole anomaly was a recurrent change in CMMoL, particularly in the proliferative type that frequently evolved to AML, no clinical features seem to characterize patients of MDS or CMMoL with isolated trisomy 19 by our review.
However, in cases of AML, the mean age of patients with isolated trisomy 19 appears to be young. Eight of the 15 patients that possess the isolated trisomy 19 were less than 10 yrs old, and four of these patients were infants, in spite of the occurrence of acute leukemia in infants was not common. A similar result was described in a report by the United Kingdom Cancer Cytogenetic Group (UKCCG) [1] regarding primary, single, autosomal trisomies associated with hematological disorders. Five of the cases described by the UKCCG report showed the presence of an isolated trisomy 19, and the mean age of these patients was significantly younger than that of the entire study group ( months, while the other presented at the age of 36 months [8] . One of our patients with AML was also less than 1 yr.
Although we failed culture to evaluate the peripheral blood cytogenetics, we can exclude the presence of constitutional trisomy 19 because he had no phenotypic abnormality.
The most reported cases of constitutional trisomy 19 were those that involved partial trisomy 19q and were associated with a distinctive phenotype that usually includes low birth weight, growth and psychomotor retardation, and facial dysmorphism etc [9] . Because no live birth with complete trisomy 19 has been reported, it can be assumed that 
